Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer RegistryJavier Gállego, Paula Jiménez Fonseca, Alberto Carmona‐Bayonas et al.|British Journal of Cancer|2017Cited by 106
Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registryAlberto Carmona‐Bayonas, Pilar Alfonso, Paula Jiménez‐Fonseca et al.|European Journal of Surgical Oncology|2018Cited by 60
Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumabJavier Gállego, Ana Custodio, Alberto Carmona‐Bayonas et al.|British Journal of Cancer|2017Cited by 49
Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancerPaula Jiménez‐Fonseca, Carlos Gómez-Martín, Alberto Carmona‐Bayonas et al.|Gastric Cancer|2016Cited by 23
Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2− advanced breast cancer: a real-world evidence cohortRodrigo Sánchez-Bayona, Miguel Martín, Alfonso López de et al.|Breast Cancer Research and Treatment|2024Cited by 21